Literature DB >> 28673024

Ancestry-Adjusted Vitamin D Metabolite Concentrations in Association With Cytochrome P450 3A Polymorphisms.

Robin Taylor Wilson1, Loren D Masters2, Jill S Barnholtz-Sloan3, Anna C Salzberg4, Terryl J Hartman5.   

Abstract

We investigated the association between genetic polymorphisms in cytochrome P450 (CYP2R1, CYP24A1, and the CYP3A family) with nonsummer plasma concentrations of vitamin D metabolites (25-hydroxyvitamin D3 (25(OH)D3) and proportion 24,25-dihydroxyvitamin D3 (24,25(OH)2D3)) among healthy individuals of sub-Saharan African and European ancestry, matched on age (within 5 years; n = 188 in each ancestral group), in central suburban Pennsylvania (2006-2009). Vitamin D metabolites were measured using high-performance liquid chromatography with tandem mass spectrometry. Paired multiple regression and adjusted least-squares mean analyses were used to test for associations between genotype and log-transformed metabolite concentrations, adjusted for age, sex, proportion of West-African genetic ancestry, body mass index, oral contraceptive (OC) use, tanning bed use, vitamin D intake, days from summer solstice, time of day of blood draw, and isoforms of the vitamin D receptor (VDR) and vitamin D binding protein. Polymorphisms in CYP2R1, CYP3A43, vitamin D binding protein, and genetic ancestry proportion remained associated with plasma 25(OH)D3 after adjustment. Only CYP3A43 and VDR polymorphisms were associated with proportion 24,25(OH)2D3. Magnitudes of association with 25(OH)D3 were similar for CYP3A43, tanning bed use, and OC use. Significant least-squares mean interactions (CYP2R1/OC use (P = 0.030) and CYP3A43/VDR (P = 0.013)) were identified. A CYP3A43 genotype, previously implicated in cancer, is strongly associated with biomarkers of vitamin D metabolism. Interactive associations should be further investigated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28673024      PMCID: PMC5888975          DOI: 10.1093/aje/kwx187

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  62 in total

1.  Association mapping in structured populations.

Authors:  J K Pritchard; M Stephens; N A Rosenberg; P Donnelly
Journal:  Am J Hum Genet       Date:  2000-05-26       Impact factor: 11.025

2.  Ancestry estimation and correction for population stratification in molecular epidemiologic association studies.

Authors:  Jill S Barnholtz-Sloan; Brian McEvoy; Mark D Shriver; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

3.  Genome-wide association study of vitamin D levels in children: replication in the Western Australian Pregnancy Cohort (Raine) study.

Authors:  D Anderson; B J Holt; C E Pennell; P G Holt; P H Hart; J M Blackwell
Journal:  Genes Immun       Date:  2014-09-11       Impact factor: 2.676

4.  Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial.

Authors:  Amy E Millen; Jean Wactawski-Wende; Mary Pettinger; Michal L Melamed; Frances A Tylavsky; Simin Liu; John Robbins; Andrea Z LaCroix; Meryl S LeBoff; Rebecca D Jackson
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

5.  Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.

Authors:  Angela M Thornton; Patricia E Korty; Dat Q Tran; Elizabeth A Wohlfert; Patrick E Murray; Yasmine Belkaid; Ethan M Shevach
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

6.  Calcitonin, estrogens and the bone.

Authors:  C Gennari; D Agnusdei
Journal:  J Steroid Biochem Mol Biol       Date:  1990-11-20       Impact factor: 4.292

7.  Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.

Authors:  Sumio Ohtsuki; Olaf Schaefer; Hirotaka Kawakami; Tae Inoue; Stephanie Liehner; Asami Saito; Naoki Ishiguro; Wataru Kishimoto; Eva Ludwig-Schwellinger; Thomas Ebner; Tetsuya Terasaki
Journal:  Drug Metab Dispos       Date:  2011-10-12       Impact factor: 3.922

8.  Vitamin D receptor polymorphism FokI and cancer risk: a comprehensive meta-analysis.

Authors:  Patrizia Gnagnarella; Elena Pasquali; Davide Serrano; Sara Raimondi; Davide Disalvatore; Sara Gandini
Journal:  Carcinogenesis       Date:  2014-07-22       Impact factor: 4.944

9.  Regulation of CYP3A4 and CYP3A5 expression and modulation of "intracrine" metabolism of androgens in prostate cells by liganded vitamin D receptor.

Authors:  Orla Maguire; Catherine Pollock; Philip Martin; Andrew Owen; Thomas Smyth; Declan Doherty; Moray J Campbell; Stephen McClean; Paul Thompson
Journal:  Mol Cell Endocrinol       Date:  2012-08-23       Impact factor: 4.102

10.  Determinants of vitamin D status in fair-skinned women of childbearing age at northern latitudes.

Authors:  Linnea Hedlund; Petra Brembeck; Hanna Olausson
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more
  2 in total

Review 1.  Interplay of Vitamin D and CYP3A4 Polymorphisms in Endocrine Disorders and Cancer.

Authors:  Siva Swapna Kasarla; Vannuruswamy Garikapati; Yashwant Kumar; Sujatha Dodoala
Journal:  Endocrinol Metab (Seoul)       Date:  2022-06-03

2.  Vitamin D and family history of hypertension in relation to hypertension status among college students.

Authors:  Yendelela L Cuffee; Ming Wang; Nathaniel R Geyer; Sangeeta Saxena; Suzanne Akuley; Lenette Jones; Robin Taylor Wilson
Journal:  J Hum Hypertens       Date:  2021-07-20       Impact factor: 2.877

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.